{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:54:14Z","timestamp":1793339654058,"version":"4.5.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.steroids.2024.109512","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T01:29:03Z","timestamp":1726277343000},"page":"109512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A review of metabolic and microbial influences on women with polycystic ovarian syndrome"],"prefix":"10.1016","volume":"212","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-3334-2587","authenticated-orcid":false,"given":"Foram K.","family":"Ravat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janki R.","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha M.","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashyap N.","family":"Thummar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.steroids.2024.109512_b0005","first-page":"168","volume":"12","author":"Evans","year":"1958","journal-title":"Polycystic Ovarian Disease (stein-Leventhal Syndrome): Etiology and Rationale for Surgical Treatment"},{"issue":"12","key":"10.1016\/j.steroids.2024.109512_b0010","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.steroids.2024.109512_b0015","series-title":"Polycystic Ovary Syndrome","first-page":"3","article-title":"Chapter 1 - Defining PCOS: A syndrome with an intrinsic heterogeneous nature","author":"Escobar-Morreale","year":"2022"},{"issue":"4","key":"10.1016\/j.steroids.2024.109512_b0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s13224-016-0848-4","article-title":"D C Dutta\u2019s textbook of gynaecology and textbook of obstetrics","volume":"66","author":"Dalal","year":"2016","journal-title":"J. Obstetr. Gynecol. India"},{"issue":"6","key":"10.1016\/j.steroids.2024.109512_b0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum. Reprod. Update"},{"issue":"23","key":"10.1016\/j.steroids.2024.109512_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192315850","article-title":"A global survey of ethnic Indian women living with polycystic ovary syndrome: co-morbidities, concerns, diagnosis experiences, quality of life, and use of treatment methods","volume":"19","author":"Rao","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.steroids.2024.109512_b0035","doi-asserted-by":"crossref","first-page":"e1071","DOI":"10.1210\/clinem\/dgaa839","article-title":"Update on PCOS: consequences, challenges, and guiding treatment","volume":"106","author":"Hoeger","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109512_b0040","doi-asserted-by":"crossref","unstructured":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertility and sterility 81(1) (2004) 19-25.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"12","key":"10.1016\/j.steroids.2024.109512_b0045","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.steroids.2024.109512_b0050","article-title":"Current guidelines for diagnosing PCOS","volume":"13","author":"Christ","year":"2023","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.steroids.2024.109512_b0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-M\u00fcllerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.steroids.2024.109512_b0060","unstructured":"B.G. Reed, B.R. Carr, The Normal Menstrual Cycle and the Control of Ovulation, in: K.R. Feingold, B. Anawalt, M.R. Blackman, A. Boyce, G. Chrousos, E. Corpas, W.W. de Herder, K. Dhatariya, K. Dungan, J. Hofland, S. Kalra, G. Kaltsas, N. Kapoor, C. Koch, P. Kopp, M. Korbonits, C.S. Kovacs, W. Kuohung, B. Laferr\u00e8re, M. Levy, E.A. McGee, R. McLachlan, M. New, J. Purnell, R. Sahay, A.S. Shah, F. Singer, M.A. Sperling, C.A. Stratakis, D.L. Trence, D.P. Wilson (Eds.), Endotext, MDText.com, Inc. Copyright \u00a9 2000-2023, MDText.com, Inc., South Dartmouth (MA), 2000."},{"key":"10.1016\/j.steroids.2024.109512_b0065","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bpobgyn.2016.03.005","article-title":"Hypothalamic\u2013pituitary, ovarian and adrenal contributions to polycystic ovary syndrome","volume":"37","author":"Baskind","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"8","key":"10.1016\/j.steroids.2024.109512_b0070","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.steroids.2024.109512_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.667422","article-title":"Central regulation of PCOS: abnormal neuronal-reproductive-metabolic circuits in PCOS pathophysiology","volume":"12","author":"Liao","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.steroids.2024.109512_b0080","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11154-016-9326-7","article-title":"Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)","volume":"16","author":"Palioura","year":"2015","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.steroids.2024.109512_b0085","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/TACG.S200341","article-title":"Genetic basis of polycystic ovary syndrome (PCOS): current perspectives","volume":"12","author":"Khan","year":"2019","journal-title":"Appl. Clin. Genet."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0090","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.fertnstert.2016.05.011","article-title":"Environmental determinants of polycystic ovary syndrome","volume":"106","author":"Merkin","year":"2016","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mehy.2012.04.016","article-title":"Dysbiosis of Gut Microbiota (DOGMA)\u2013a novel theory for the development of Polycystic Ovarian Syndrome","volume":"79","author":"Tremellen","year":"2012","journal-title":"Med. Hypotheses"},{"issue":"8","key":"10.1016\/j.steroids.2024.109512_b0100","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota\u2013bile acid\u2013interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.steroids.2024.109512_b0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diabres.2017.06.011","article-title":"Insulin and the Polycystic Ovary Syndrome","volume":"130","author":"Macut","year":"2017","journal-title":"Diab. Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.steroids.2024.109512_b0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1515\/jtim-2016-0018","article-title":"Obesity diabetes and the role of bile acids in metabolism","volume":"4","author":"Tomkin","year":"2016","journal-title":"J. Transl. Internal Med."},{"key":"10.1016\/j.steroids.2024.109512_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2022.120380","article-title":"Assessing the role of the gut microbiome at the interface between environmental chemical exposures and human health: current knowledge and challenges","volume":"315","author":"Campana","year":"2022","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.steroids.2024.109512_b0120","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.aivir.2017.02.001","article-title":"Chapter Two - Metabolomics: Strategies to Define the Role of Metabolism in Virus Infection and Pathogenesis","author":"Manchester","year":"2017"},{"issue":"4","key":"10.1016\/j.steroids.2024.109512_b0125","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.steroids.2024.109512_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061983","article-title":"A recent ten-year perspective: bile acid metabolism and signaling","volume":"27","author":"Shulpekova","year":"2022","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"10","key":"10.1016\/j.steroids.2024.109512_b0135","first-page":"1243","volume":"54","author":"Simbrunner","year":"2021","journal-title":"Review Article: Therapeutic Aspects of Bile Acid Signalling in the Gut-Liver Axis"},{"issue":"3","key":"10.1016\/j.steroids.2024.109512_b0140","article-title":"Bile salt hydrolases: Gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract","volume":"15","author":"Knoll","year":"2019","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.steroids.2024.109512_b0145","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.steroids.2024.109512_b0150","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jsbmb.2019.03.005","article-title":"Increased circulating conjugated primary bile acids are associated with hyperandrogenism in women with polycystic ovary syndrome","volume":"189","author":"Zhang","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"10.1016\/j.steroids.2024.109512_b0155","doi-asserted-by":"crossref","first-page":"e7333","DOI":"10.1371\/journal.pone.0007333","article-title":"The bile acid synthesis pathway is present and functional in the human ovary","volume":"4","author":"Smith","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.steroids.2024.109512_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11120845","article-title":"Profile of bile acid metabolomics in the follicular fluid of PCOS patients","volume":"11","author":"Yang","year":"2021","journal-title":"Metabolites"},{"issue":"7","key":"10.1016\/j.steroids.2024.109512_b0165","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.steroids.2024.109512_b0170","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab118","article-title":"Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome","volume":"162","author":"Yang","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2024.109512_b0175","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/whr.2022.0060","article-title":"Diagnostic value of bile acids and fibroblast growth factor 21 in women with polycystic ovary syndrome","volume":"3","author":"Yoost","year":"2022","journal-title":"Women's Health Rep."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0180","doi-asserted-by":"crossref","first-page":"22184","DOI":"10.1038\/s41598-022-25041-4","article-title":"Gut microbiome in PCOS associates to serum metabolomics: a cross-sectional study","volume":"12","author":"Yu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.steroids.2024.109512_b0185","doi-asserted-by":"crossref","first-page":"1239276","DOI":"10.3389\/fendo.2023.1239276","article-title":"Circulating bile acid profile characteristics in PCOS patients and the role of bile acids in predicting the pathogenesis of PCOS","volume":"14","author":"Yu","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.steroids.2024.109512_b0190","doi-asserted-by":"crossref","unstructured":"M. Arumugam, J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, D.R. Mende, G.R. Fernandes, J. Tap, T. Bruls, J.M. Batto, M. Bertalan, N. Borruel, F. Casellas, L. Fernandez, L. Gautier, T. Hansen, M. Hattori, T. Hayashi, M. Kleerebezem, K. Kurokawa, M. Leclerc, F. Levenez, C. Manichanh, H.B. Nielsen, T. Nielsen, N. Pons, J. Poulain, J. Qin, T. Sicheritz-Ponten, S. Tims, D. Torrents, E. Ugarte, E.G. Zoetendal, J. Wang, F. Guarner, O. Pedersen, W.M. de Vos, S. Brunak, J. Dor\u00e9, M. Antol\u00edn, F. Artiguenave, H.M. Blottiere, M. Almeida, C. Brechot, C. Cara, C. Chervaux, A. Cultrone, C. Delorme, G. Denariaz, R. Dervyn, K.U. Foerstner, C. Friss, M. van de Guchte, E. Guedon, F. Haimet, W. Huber, J. van Hylckama-Vlieg, A. Jamet, C. Juste, G. Kaci, J. Knol, O. Lakhdari, S. Layec, K. Le Roux, E. Maguin, A. M\u00e9rieux, R. Melo Minardi, C. M'Rini, J. Muller, R. Oozeer, J. Parkhill, P. Renault, M. Rescigno, N. Sanchez, S. Sunagawa, A. Torrejon, K. Turner, G. Vandemeulebrouck, E. Varela, Y. Winogradsky, G. Zeller, J. Weissenbach, S.D. Ehrlich, P. Bork, Enterotypes of the human gut microbiome, Nature 473(7346) (2011) 174-80.","DOI":"10.1038\/nature09944"},{"key":"10.1016\/j.steroids.2024.109512_b0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1126\/science.aad2602","article-title":"The ecology of the microbiome: Networks, competition, and stability","volume":"350","author":"Coyte","year":"2015","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.steroids.2024.109512_b0200","doi-asserted-by":"crossref","first-page":"1018594","DOI":"10.3389\/fmicb.2022.1018594","article-title":"The gut microbiome in human health and disease-Where are we and where are we going? A bibliometric analysis","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Microbiol."},{"issue":"7581","key":"10.1016\/j.steroids.2024.109512_b0205","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature15766","article-title":"Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota","volume":"528","author":"Forslund","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1017\/S0954422416000287","article-title":"Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges","volume":"30","author":"Jeanes","year":"2017","journal-title":"Nutr. Res. Rev."},{"key":"10.1016\/j.steroids.2024.109512_b0215","first-page":"324","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.resmic.2018.09.002","article-title":"Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study","volume":"170","author":"Zeng","year":"2019","journal-title":"Res. Microbiol."},{"issue":"8","key":"10.1016\/j.steroids.2024.109512_b0225","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0230","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/EC-19-0522","article-title":"Characteristic gut microbiota and predicted metabolic functions in women with PCOS","volume":"9","author":"Zhou","year":"2020","journal-title":"Endocr. Connect."},{"issue":"11","key":"10.1016\/j.steroids.2024.109512_b0235","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1139\/cjpp-2019-0413","article-title":"Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report","volume":"98","author":"Liang","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.steroids.2024.109512_b0240","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.fertnstert.2020.01.027","article-title":"Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome","volume":"113","author":"Chu","year":"2020","journal-title":"Fertil. Steril."},{"issue":"8","key":"10.1016\/j.steroids.2024.109512_b0245","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s40618-020-01481-5","article-title":"Gut microbiota alterations reveal potential gut\u2013brain axis changes in polycystic ovary syndrome","volume":"44","author":"Liang","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0250","doi-asserted-by":"crossref","first-page":"e0168390","DOI":"10.1371\/journal.pone.0168390","article-title":"Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study","volume":"12","author":"Lindheim","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.steroids.2024.109512_b0255","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1210\/jc.2017-02799","article-title":"Gut microbiota and the polycystic ovary syndrome: influence of sex, sex hormones, and obesity","volume":"103","author":"Insenser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.steroids.2024.109512_b0260","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.steroids.2024.109512_b0265","doi-asserted-by":"crossref","first-page":"e2134","DOI":"10.1210\/clinem\/dgz263","article-title":"Obese adolescents with PCOS have altered biodiversity and relative abundance in gastrointestinal microbiota","volume":"105","author":"Jobira","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.steroids.2024.109512_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061622","article-title":"Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics","volume":"12","author":"Haudum","year":"2020","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.steroids.2024.109512_b0275","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa600","article-title":"Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome","volume":"105","author":"Eyupoglu","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.steroids.2024.109512_b0280","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1210\/clinem\/dgaa848","article-title":"The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits","volume":"106","author":"L\u00fcll","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.steroids.2024.109512_b0285","doi-asserted-by":"crossref","first-page":"e12734","DOI":"10.1111\/ijpo.12734","article-title":"Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments","volume":"16","author":"Garcia-Beltran","year":"2021","journal-title":"Pediatr. Obes."},{"issue":"2","key":"10.1016\/j.steroids.2024.109512_b0290","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3390\/genes13020379","article-title":"Bifidobacterium is enriched in gut microbiome of Kashmiri women with polycystic ovary syndrome","volume":"13","author":"Hassan","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.steroids.2024.109512_b0295","doi-asserted-by":"crossref","unstructured":"J. Guo, J. Shao, Y. Yang, X. Niu, J. Liao, Q. Zhao, D. Wang, S. Li, J. Hu, Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review, Reproductive Sciences (Thousand Oaks, Calif.) (2021).","DOI":"10.1007\/s43032-020-00430-0"},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0300","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tem.2018.11.001","article-title":"Sex, microbes, and polycystic ovary syndrome","volume":"30","author":"Thackray","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.steroids.2024.109512_b0305","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dei104","article-title":"Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study","volume":"20","author":"Penna","year":"2005","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.steroids.2024.109512_b0310","article-title":"Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0315","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/01443615.2019.1604644","article-title":"Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study","volume":"40","author":"Advani","year":"2020","journal-title":"J. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.37072\/JCS.2020.01.02","article-title":"Intestinal microbiota in the polycystic ovary syndrome","volume":"3","author":"Cojocaru","year":"2020","journal-title":"J. Clin. Sexol."},{"issue":"6","key":"10.1016\/j.steroids.2024.109512_b0325","doi-asserted-by":"crossref","first-page":"e1003132","DOI":"10.1371\/journal.pmed.1003132","article-title":"Distinct subtypes of polycystic ovary syndrome with novel genetic associations: an unsupervised, phenotypic clustering analysis","volume":"17","author":"Dapas","year":"2020","journal-title":"PLoS Med."},{"issue":"12","key":"10.1016\/j.steroids.2024.109512_b0330","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1210\/clinem\/dgaa600","article-title":"Gut microbiota and oral contraceptive use in overweight and obese patients with polycystic ovary syndrome","volume":"105","author":"Eyupoglu","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-17183-8","article-title":"Bile acids drive the newborn\u2019s gut microbiota maturation","volume":"11","author":"Van Best","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.steroids.2024.109512_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113262","article-title":"Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes","volume":"185","author":"Zhou","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.steroids.2024.109512_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.hnm.2022.200174","article-title":"Fat mass and Obesity Associated (FTO) gene and polycystic ovary syndrome: Insight into pathogenesis and association with insulin resistance","volume":"30","author":"Parveen","year":"2022","journal-title":"Human Nutrition & Metabolism"},{"key":"10.1016\/j.steroids.2024.109512_b0350","doi-asserted-by":"crossref","first-page":"9240569","DOI":"10.1155\/2022\/9240569","article-title":"Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature","volume":"2022","author":"Xu","year":"2022","journal-title":"Journal of Healthcare Engineering"},{"issue":"5","key":"10.1016\/j.steroids.2024.109512_b0355","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.steroids.2024.109512_b0360","first-page":"827","volume":"112","author":"Greenwood","year":"2019","journal-title":"Sterility, Insulin Resistance in Polycystic Ovary Syndrome: Concept versus Cutoff"},{"issue":"10","key":"10.1016\/j.steroids.2024.109512_b0365","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1210\/clinem\/dgaa425","article-title":"Metabolism, Effect of diet on insulin resistance in polycystic ovary syndrome","volume":"105","author":"Shang","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109512_b0370","doi-asserted-by":"crossref","unstructured":"S. Cassar, M.L. Misso, W.G. Hopkins, C.S. Shaw, H.J. Teede, N.K.J.H.r. Stepto, Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic\u2013hyperinsulinaemic clamp studies, 31(11) (2016) 2619-2631.","DOI":"10.1093\/humrep\/dew243"},{"key":"10.1016\/j.steroids.2024.109512_b0375","series-title":"Obesity and Lipotoxicity","first-page":"221","article-title":"The Pathogenesis of Obesity-Associated Adipose Tissue Inflammation","author":"Engin","year":"2017"},{"key":"10.1016\/j.steroids.2024.109512_b0380","article-title":"The Release of Peripheral Immune Inflammatory Cytokines Promote an Inflammatory Cascade in PCOS Patients via Altering the Follicular Microenvironment","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.steroids.2024.109512_b0385","unstructured":"T. Sonwani, PCOS in obesity: Indian scenario."},{"key":"10.1016\/j.steroids.2024.109512_b0390","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"issue":"3","key":"10.1016\/j.steroids.2024.109512_b0395","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.yfrne.2010.06.002","article-title":"Leptin in human physiology and therapeutics","volume":"31","author":"Dardeno","year":"2010","journal-title":"Front. Neuroendocrinol."},{"issue":"12","key":"10.1016\/j.steroids.2024.109512_b0400","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00109-007-0246-6","article-title":"Accumulation of dietary glycotoxins in the reproductive system of normal female rats","volume":"85","author":"Diamanti-Kandarakis","year":"2007","journal-title":"J. Mol. Med. (Berl)"},{"issue":"5","key":"10.1016\/j.steroids.2024.109512_b0405","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1210\/jc.2015-3776","article-title":"Variants in FSHB Are Associated With Polycystic Ovary Syndrome and Luteinizing Hormone Level in Han Chinese Women","volume":"101","author":"Tian","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2024.109512_b0410","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease","volume":"50","author":"Burghen","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2024.109512_b0415","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000485995","article-title":"Metabolic Syndrome in Polycystic Ovary Syndrome","volume":"49","author":"Pasquali","year":"2018","journal-title":"Front. Horm. Res."},{"issue":"5","key":"10.1016\/j.steroids.2024.109512_b0420","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrendo.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.steroids.2024.109512_b0425","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.rbmo.2020.05.005","article-title":"Verification of a ZBTB16 variant in polycystic ovary syndrome patients","volume":"41","author":"Yang","year":"2020","journal-title":"Reprod. Biomed. Online"},{"issue":"2","key":"10.1016\/j.steroids.2024.109512_b0430","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00017-19","article-title":"Probiotic bifidobacterium lactis V9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis","volume":"4","author":"Zhang","year":"2019","journal-title":"mSystems"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24001508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X24001508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T06:58:48Z","timestamp":1731999528000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X24001508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":86,"alternative-id":["S0039128X24001508"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109512","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A review of metabolic and microbial influences on women with polycystic ovarian syndrome","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2024.109512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109512"}}